BIOLASE Inc (BIOL) is higher by Friday morning, with the stock adding 10614.29% in pre-market trading to 7.5. BIOL's short-term technical score of 44 indicates that the stock has traded less bullishly over the last month than 56% of stocks on the market. In the Medical Devices industry, which ranks 107 out of 146 industries, the stock ranks higher than 59% of stocks. BIOLASE Inc has fallen 12.50% over the past month, closing at $0.07 on June 30. During this period of time, the stock fell as low as $0.07 and as high as $0.10. BIOL has an average analyst recommendation of Strong Buy. The company has an average price target of $0.90.
BIOL has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on BIOL!